Alexion Pharma to acquire Syntimmune in $1.2B deal

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Wednesday, Alexion Pharmaceuticals stated it would acquire the privately-owned biotech firm Syntimmune in a deal valuing the company at about $1.2B, boosting its portfolio of drug treatments for rare disorders.
Back to articles

Actual Topics

Wed, 26 Sep 2018 16:02:46 GMT

Russia's lawmakers move closer to increase retirement age

On Wednesday, Russian lawmakers moved closer to approve divisive measures to increase the country's retirement age.

Wed, 26 Sep 2018 14:56:14 GMT

Anbang Insurance seeks selling Japanese real estate to Blackstone

Anbang Insurance Group is considering to sell its Japan real estate worth $200M to bidders, such as Blackstone Group, almost two years after acquiring them from the US investment fund.

Subscribe to "Fundamental Analysis" feed

订阅
欲了解更多有关杜高斯贝银行差价合约/外汇交易平台，SWFX和其它相关交易详情，
请致电我们或要求回电。
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
欲了解更多有关杜高斯贝银行差价合约/外汇交易平台，SWFX和其它相关交易详情，
请致电我们或要求回电。
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.